HESI CASE STUDY ADVANCED CARDIAC LIFE SUPPORT SEPSIS –ACLS 2024
HESI CASE STUDY ADVANCED CARDIAC LIFE SUPPORT SEPSIS –ACLS 2024 Role of thrombolytic therapy and angioplasty/stent --------- Answer --------- Treatment within 1 hour- mortality 1% Delayed treatment >1 hr- mortality 10% No treatment- mortality 15% Sudden Death Syndrome High Risk --------- Answer --------- CAD Cardiomyopathy LVEF <40% Frequent ventricular ectopy Sudden Death Syndrome --------- Answer --------- High Risk Asytole V Tach (common underlying problem) Bradycardia Primary V. Fib
Escuela, estudio y materia
- Institución
- HESI CASE STUDY ADVANCED CARDIAC LIFE SUPPORT
- Grado
- HESI CASE STUDY ADVANCED CARDIAC LIFE SUPPORT
Información del documento
- Subido en
- 13 de febrero de 2024
- Número de páginas
- 10
- Escrito en
- 2023/2024
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
Temas
-
hesi case study
-
hesi case study advanced cardiac life support
-
advanced cardiac life support sepsis
-
advanced cardiac life support sepsis
Documento también disponible en un lote